A Modest Premium for Taking the RiskThin moat

Intuitive Surgical (ISRG) — moat facet

Intuitive charges more for a lease and says exactly why: the time value of money, and the risk that the machine is not used enough.

Intuitive is explicit about how it prices the arrangements it is placing fastest: "We generally set fixed-payment and usage-based operating lease arrangements' pricing at a modest premium relative to purchased systems reflecting the time value of money and, in the case of usage-based operating lease arrangements, the risk that system utilization may fall short of anticipated levels."1

Gross margin as the lease book grows (%)66.0%202567.8%Q2 202668.0%2026 guide low69.0%2026 guide highIntuitive says lease transactions generate similar gross margins to sales.
The premium is compensation for the time value of money and for the risk that utilisation falls short. Margin holding as leasing grows is the underwriting working.

That single sentence contains the whole trade. Intuitive charges more, in aggregate, for a leased system than for a sold one — as any financier would — and the premium is compensation for two distinct risks it has agreed to carry: the cost of money over the term, and the possibility that the hospital does not operate as often as either party expects.

It also confirms that Intuitive believes it prices the risk correctly, which is a testable claim. The company adds that "generally, lease transactions generate similar gross profit margins as our sale transactions" — so on its own numbers the premium roughly compensates for the financing, and the utilisation risk is where the outcome is uncertain.

There is a structural reason to think the underwriting is sound. Usage-based arrangements are offered to "qualified customers that have committed da Vinci programs"2 — established users with a procedure history — rather than to new adopters. The riskiest customers get fixed-payment leases or buy outright.

And there is a customer-side benefit that matters more than the pricing. Variable arrangements "create better matching of reimbursements and cost for our customers"3: a hospital paying per procedure is paying out of the reimbursement that same procedure generates, which removes the mismatch that makes robotics programmes financially frightening to run.

Compare gross margin as the lease book grows: 66.0% in 2025 and 67.8% in the June 2026 quarter4, against guidance of 68.0-69.0% on a non-GAAP basis. Holding is the pricing working.

Moat trajectory: Holding steady

Intuitive still charges more for a lease than a purchase and still names the same two reasons: the time value of money and the risk that the system is under-used. The premium has not moved with the guidance.

The number that tests this moat
Reported
Variable (usage-based) lease revenue
$531M in 2025, from $338M and $217M

Leases billed by use shift the utilisation risk to Intuitive. This revenue growing faster than placements shows the risk paying; a slowdown with more usage-based systems in the field would show hospitals using them less than expected.

Source: Intuitive Surgical Form 10-K, FY2025 ↗
⚠ Threats to the moat
⚠ THREAT 01
A Premium Priced for One Growth Rate Is Mispriced at Another
The utilisation risk premium was set when procedures grew 18%. Guidance is now 13.5% to 15.5%.
References
  1. ReportedIntuitive is explicit about how it prices the arrangements it is placing fastest: "We generally set fixed-payment and usage-based operating lease arrangements' pricing at a modest premium relative to purchased systems reflecting the time...
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, results of operations (instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M, recurring revenue $8,465.3M, gross margin 66.0%, operating income $2,945.5M, average selling price, lease revenue recognition, and the discussion of procedure categories) — FY2025 · publ. February 3, 2026 · source ↗
  2. ReportedUsage-based arrangements are offered to "qualified customers that have committed da Vinci programs" — established users with a procedure history — rather than to new adopters.
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, results of operations (instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M, recurring revenue $8,465.3M, gross margin 66.0%, operating income $2,945.5M, average selling price, lease revenue recognition, and the discussion of procedure categories) — FY2025 · publ. February 3, 2026 · source ↗
  3. ReportedVariable arrangements "create better matching of reimbursements and cost for our customers": a hospital paying per procedure is paying out of the reimbursement that same procedure generates, which removes the mismatch that makes robotics...
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, results of operations (instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M, recurring revenue $8,465.3M, gross margin 66.0%, operating income $2,945.5M, average selling price, lease revenue recognition, and the discussion of procedure categories) — FY2025 · publ. February 3, 2026 · source ↗
  4. ReportedCompare gross margin as the lease book grows: 66.0% in 2025 and 67.8% in the June 2026 quarter, against guidance of 68.0-69.0% on a non-GAAP basis.
    Intuitive Surgical Q2 2026 earnings call - the Extended Use Program raising permitted uses on selected EndoWrist instruments from the first half of 2027, US da Vinci procedure growth of 12% against 14% attributed to the expiry of enhanced Affordable Care Act premium subsidies, full-year guidance of 13.5% to 15.5% nearer the midpoint, gross-margin guidance raised to 68-69%, and Japanese placements of 25 against 15 — Q2 2026 · publ. July 16, 2026 · source ↗
Sources
Generated September 23, 2026